Immuno-Modulatory Effects of Dexamethasone in Severe COVID-19—A Swedish Cohort Study

Dexamethasone (Dex) has been shown to decrease mortality in severe coronavirus disease 2019 (COVID-19), but the mechanism is not fully elucidated. We aimed to investigate the physiological and immunological effects associated with Dex administration in patients admitted to intensive care with severe...

Descripción completa

Detalles Bibliográficos
Autores principales: Asif, Sana, Frithiof, Robert, Larsson, Anders, Franzén, Stephanie, Anderberg, Sara Bülow, Kristensen, Bjarne, Hultström, Michael, Lipcsey, Miklos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855905/
https://www.ncbi.nlm.nih.gov/pubmed/36672672
http://dx.doi.org/10.3390/biomedicines11010164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855905/
https://www.ncbi.nlm.nih.gov/pubmed/36672672
http://dx.doi.org/10.3390/biomedicines11010164

Ejemplares similares